Ewch i’r prif gynnwys
Duncan Baird

Yr Athro Duncan Baird

Comment
Sylwebydd y cyfryngau

Timau a rolau for Duncan Baird

Trosolwyg

Duncan Baird is a professor of Cancer and Genetics and is the sub-division lead for Genetic and Genome Medicine within the Division of Cancer and Genetics. His research group focuses on telomere biology and is funded by Cancer Research UK, the US NIH, Blood Cancer UK, Cancer Research Wales and Health and Care Research Wales

Cyhoeddiad

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2000

1999

1997

1995

1994

Articles

Book sections

Ymchwil

Telomeres are structures that cap the ends of chromosomes, they prevent the natural end of a chromosome from being recognised as a double-stranded DNA break. Telomeres shorten with ongoing cell division ultimately obtaining a length at which they become dysfunctional. Dysfunctional telomeres may either trigger replicative senescence or undergo fusion with other chromosome ends or non-telomeric DNA breaks. Fusion can result in the formation dicentric chromosomes and cycles of anaphase bridging, breakage and fusion, which in turn can cause large-scale, potentially oncogenic, genomic rearrangements such as non-reciprocal translocations.

The laboratory has developed high-resolution single molecule approaches to determine telomere length and to detect telomere fusion. They have been using these tools to understand the mechanisms of telomere erosion, mutation and fusion, as well undertaking translational work to examine the role of telomere dysfunction in tumour progression and to test the utility of telomere based prognostic markers in several tumour types.

Addysgu

Lecturer on the ‘Molecular and Cell Biology of Cancer’ module for the Medical Intercalated degree for 3rd and 4th year students from the Schools of Medicine and Dentistry.

Academic mentor for undergraduate medical students.

My laboratory hosts SSC medical student projects.

Host 3rd year Pharmacology Student Research Projects.

Supervision of full-time PhD students

Bywgraffiad

Aelodaethau proffesiynol

Meysydd goruchwyliaeth

Goruchwyliaeth gyfredol

Angelos Damo

Angelos Damo

Alex Kearsey

Alex Kearsey

News articles

Mae Ymddiriedolaeth Myristica wedi dyfarnu £2 miliwn i Brifysgol Caerdydd i gryfhau ymchwil canser trosiadol drwy brynu technoleg flaengar a chreu tair ysgoloriaeth PhD.

Rhodd gwerth £2 miliwn i drawsnewid ymchwil canser trosiadol

13 March 2026

Mae Ymddiriedolaeth Myristica wedi dyfarnu £2 miliwn i Brifysgol Caerdydd i gryfhau ymchwil canser trosiadol drwy brynu technoleg flaengar a chreu tair ysgoloriaeth PhD.

Mae gwyddonwyr Prifysgol Caerdydd yn datrys dirgelwch 'aileni cromosom' sy'n sail i ffurfio canser.

Mewnwelediadau newydd i fwtaniadau cromosom anhrefnus

10 March 2026

Mae gwyddonwyr Prifysgol Caerdydd yn datrys dirgelwch 'aileni cromosom' sy'n sail i ffurfio canser.

Diolch i'r rhodd fwyaf hyd yma gan Ymddiriedolaeth Myristica, gellir cefnogi naw PhD.

£1 miliwn o gyllid ar gyfer ysgoloriaethau ymchwil canser

29 January 2024

Diolch i'r rhodd fwyaf hyd yma gan Ymddiriedolaeth Myristica, gellir cefnogi naw PhD.

Bydd technoleg cydraniad uchel newydd yn 'gweddnewid' y broses o brofi am anhwylderau sy’n gysylltiedig â’r telomerau

Gwyddonwyr wedi datblygu prawf cyflym ar gyfer gwneud diagnosis o set o gyflyrau genetig prin

17 March 2021

Bydd technoleg cydraniad uchel newydd yn 'gweddnewid' y broses o brofi am anhwylderau sy’n gysylltiedig â’r telomerau

Gall prawf newydd ragfynegi sut fydd pobl gyda lewcemia'n ymateb i gemotherapi

‘Trobwynt’ ar gyfer trin lewcemia lymffosytig cronig

04 March 2019

Gall prawf newydd ragfynegi sut fydd pobl gyda lewcemia'n ymateb i gemotherapi

Prawf newydd yn fwy effeithiol o ran rhagweld cyfraddau goroesi cleifion sydd â chanser yn y gwaed

Prawf gwaed newydd i ganser

11 May 2017

Prawf newydd yn fwy effeithiol o ran rhagweld cyfraddau goroesi cleifion sydd â chanser yn y gwaed

Contact Details